Literature DB >> 30300584

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.

Roberta Zappasodi, Taha Merghoub, Jedd D Wolchok.   

Abstract

Entities:  

Year:  2018        PMID： 30300584      PMCID： PMC6222254          DOI： 10.1016/j.ccell.2018.09.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  21 in total

1.  cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.

Authors:  Zining Wang; Jiemin Chen; Jie Hu; Hongxia Zhang; Feifei Xu; Wenzhuo He; Xiaojuan Wang; Mengyun Li; Wenhua Lu; Gucheng Zeng; Penghui Zhou; Peng Huang; Siyu Chen; Wende Li; Liang-Ping Xia; Xiaojun Xia
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

2.  An engineered 4-1BBL fusion protein with "activity on demand".

Authors:  Jacqueline Mock; Marco Stringhini; Alessandra Villa; Michael Weller; Tobias Weiss; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

Review 3.  Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.

Authors:  Gavin P Dunn; Timothy F Cloughesy; Marcela V Maus; Robert M Prins; David A Reardon; Adam M Sonabend
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

4.  An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.

Authors:  Leonid Cherkassky; Masanori Oshi; Eihab Abdelfatah; Rongrong Wu; Yamato Takabe; Li Yan; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

5.  OBIF: an omics-based interaction framework to reveal molecular drivers of synergy.

Authors:  Jezreel Pantaleón García; Vikram V Kulkarni; Tanner C Reese; Shradha Wali; Saima J Wase; Jiexin Zhang; Ratnakar Singh; Mauricio S Caetano; Humam Kadara; Seyed Javad Moghaddam; Faye M Johnson; Jing Wang; Yongxing Wang; Scott E Evans
Journal:  NAR Genom Bioinform       Date:  2022-04-05

6.  Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade.

Authors:  Melissa A Galati; Karl P Hodel; Zachary F Pursell; Uri Tabori; Miki S Gams; Sumedha Sudhaman; Taylor Bridge; Walter J Zahurancik; Nathan A Ungerleider; Vivian S Park; Ayse B Ercan; Lazar Joksimovic; Iram Siddiqui; Robert Siddaway; Melissa Edwards; Richard de Borja; Dana Elshaer; Jiil Chung; Victoria J Forster; Nuno M Nunes; Melyssa Aronson; Xia Wang; Jagadeesh Ramdas; Andrea Seeley; Tomasz Sarosiek; Gavin P Dunn; Jonathan N Byrd; Oz Mordechai; Carol Durno; Alberto Martin; Adam Shlien; Eric Bouffet; Zucai Suo; James G Jackson; Cynthia E Hawkins; Cynthia J Guidos
Journal:  Cancer Res       Date:  2020-09-16       Impact factor: 12.701

7.  Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma.

Authors:  Sadna Budhu; Rachel Giese; Aditi Gupta; Kelly Fitzgerald; Roberta Zappasodi; Sara Schad; Daniel Hirschhorn; Luis Felipe Campesato; Olivier De Henau; Mathieu Gigoux; Cailian Liu; Gregory Mazo; Liang Deng; Christopher A Barker; Jedd D Wolchok; Taha Merghoub
Journal:  Cell Rep       Date:  2021-01-12       Impact factor: 9.423

8.  Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.

Authors:  Ahreum Kim; Sun Min Lim; Joo-Hang Kim; Jeong-Sun Seo
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

9.  Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation.

Authors:  Julie Terzic; Amanda Seipel; Jean Dubuisson; Jean-Christophe Tille; Petros Tsantoulis; Alfredo Addeo; S Intidhar Labidi-Galy
Journal:  Gynecol Oncol Rep       Date:  2020-06-15

10.  Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy.

Authors:  Si-Yuan Zhang; Xian-Yue Ren; Chun-Yang Wang; Xi-Juan Chen; Ruo-Yan Cao; Qin Liu; Xue Pan; Jia-Ying Zhou; Wei-Lin Zhang; Xin-Ran Tang; Bin Cheng; Tong Wu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.